|
Delayed
OTC Markets
11:08:29 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.007300 USD | +1,725.00% |
|
0.00% | -97.61% |
| 04-15 | CS Diagnostics Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-14 | CS Diagnostics Corp. Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: CS Diagnostics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Market Cap 1 | 0.3951 | 150.6 | 76.47 |
| Change | - | 38,005.96% | -49.21% |
| Enterprise Value (EV) 1 | 0.3747 | 150.6 | 76.47 |
| Change | - | 40,076.48% | -49.21% |
| P/E | -2,525x | 232,000x | 1,077x |
| PBR | 0.11x | 0.32x | 0.15x |
| PEG | - | -2,263x | 0x |
| Capitalization / Revenue | 3.13x | 1,357x | 375x |
| EV / Revenue | 2.97x | 1,357x | 375x |
| EV / EBITDA | - | - | - |
| EV / EBIT | -17x | 197,840x | 1,074x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.000198 | 0.000005 | 0.000284 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.126 | 0.1109 | 0.204 |
| EBITDA | - | - | - |
| EBIT 1 | -0.022 | 0.000761 | 0.0712 |
| Net income 1 | -0.022 | 0.000761 | 0.0712 |
| Net Debt 1 | -0.0204 | -0.000501 | -0.006813 |
| Reference price 2 | 0.500000 | 1.160000 | 0.305900 |
| Nbr of stocks (in thousands) | 790 | 129,790 | 249,992 |
| Announcement Date | 7/29/25 | 7/29/25 | 4/15/26 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 1.82M | ||
| 33.95x | 4.03x | 15.12x | 2.53% | 178B | ||
| 23.66x | 4.63x | 16.25x | 1.18% | 117B | ||
| 20.38x | 3.52x | 12.6x | 2.99% | 116B | ||
| 31.19x | 3.01x | 12.15x | 2.29% | 91.03B | ||
| 17.79x | 0.21x | 12.9x | 0.73% | 61.89B | ||
| 31.8x | 7.97x | 20.49x | 1.24% | 55.85B | ||
| 38.71x | 3.58x | 12.19x | 2.14% | 53.16B | ||
| 38.13x | 9.47x | 26.48x | -.--% | 44.35B | ||
| 40.31x | 3.26x | 12.12x | 0.53% | 33.59B | ||
| Average | 30.66x | 4.41x | 15.59x | 1.52% | 75.01B | |
| Weighted average by Cap. | 29.29x | 4.15x | 15.09x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSDX Stock
- Valuation CS Diagnostics Corp.
Select your edition
All financial news and data tailored to specific country editions
















